1. Home
  2. AADI vs GROW Comparison

AADI vs GROW Comparison

Compare AADI & GROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AADI
  • GROW
  • Stock Information
  • Founded
  • AADI 2011
  • GROW 1968
  • Country
  • AADI United States
  • GROW United States
  • Employees
  • AADI N/A
  • GROW N/A
  • Industry
  • AADI Biotechnology: Pharmaceutical Preparations
  • GROW Investment Managers
  • Sector
  • AADI Health Care
  • GROW Finance
  • Exchange
  • AADI Nasdaq
  • GROW Nasdaq
  • Market Cap
  • AADI 33.6M
  • GROW 36.8M
  • IPO Year
  • AADI N/A
  • GROW N/A
  • Fundamental
  • Price
  • AADI $1.50
  • GROW $2.61
  • Analyst Decision
  • AADI Buy
  • GROW
  • Analyst Count
  • AADI 2
  • GROW 0
  • Target Price
  • AADI $5.00
  • GROW N/A
  • AVG Volume (30 Days)
  • AADI 340.3K
  • GROW 24.4K
  • Earning Date
  • AADI 08-07-2024
  • GROW 05-09-2024
  • Dividend Yield
  • AADI N/A
  • GROW 3.40%
  • EPS Growth
  • AADI N/A
  • GROW 100.00
  • EPS
  • AADI N/A
  • GROW 0.12
  • Revenue
  • AADI $23,840,000.00
  • GROW $11,854,000.00
  • Revenue This Year
  • AADI $4.21
  • GROW N/A
  • Revenue Next Year
  • AADI $8.61
  • GROW N/A
  • P/E Ratio
  • AADI N/A
  • GROW $21.67
  • Revenue Growth
  • AADI 26.97
  • GROW N/A
  • 52 Week Low
  • AADI $1.28
  • GROW $2.47
  • 52 Week High
  • AADI $7.24
  • GROW $3.30
  • Technical
  • Relative Strength Index (RSI)
  • AADI 44.77
  • GROW 51.12
  • Support Level
  • AADI $1.32
  • GROW $2.55
  • Resistance Level
  • AADI $1.42
  • GROW $2.65
  • Average True Range (ATR)
  • AADI 0.10
  • GROW 0.04
  • MACD
  • AADI -0.00
  • GROW 0.01
  • Stochastic Oscillator
  • AADI 42.31
  • GROW 59.88

About AADI Aadi Bioscience Inc.

Aadi Bioscience Inc is a clinical-stage biopharmaceutical company developing precision therapies for genetically-defined cancers. Aadi's primary goal is to bring transformational therapies to cancer patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes, where other mTOR inhibitors have not or cannot be effectively exploited due to problems of pharmacology, effective drug delivery, safety, or effective targeting to the disease site. It has one operating segment, which is the business of developing and commercializing proprietary therapeutic. Geographically, it is located in the United States.

About GROW U.S. Global Investors Inc.

US Global Investors Inc is a registered investment advisory firm. The company furnishes an investment program for each of the clients it manages and determines, subject to overall supervision by the applicable board of trustees of the clients, the clients investments pursuant to an advisory agreement. US Global manages the following business segments: Investment management services; Investment management services; and Corporate Investments. It derives all its revenue from Investment management services.

Share on Social Networks: